Laws · international

Indian Editorial Urges Cannabis Reform as Policy Debate Gains Ground

The Statesman calls for India to reconsider cannabis prohibition amid growing global momentum for legalization.

By Marcus Vela, Editor-in-ChiefPublished July 14, 20263 min read
View of Rashtrapati Bhavan in New Delhi with manicured gardens and sunrise sky.

View of Rashtrapati Bhavan in New Delhi with manicured gardens and sunrise sky.

An editorial published July 14, 2026 in The Statesman argued that India should pursue cannabis reform, joining a growing chorus of voices pushing for policy change in a country where cannabis has deep cultural and medicinal roots but remains subject to strict prohibition under the Narcotic Drugs and Psychotropic Substances Act of 1985.

Editorial Breaks With Prohibition Orthodoxy

The Statesman editorial marks a significant mainstream media intervention in India's cannabis policy debate. The piece appeared in one of India's oldest English-language dailies. It comes as reform advocates cite the country's historical use of cannabis in Ayurvedic medicine and religious practice as grounds for reconsidering blanket prohibition.

India criminalized cannabis in 1985 under pressure from international drug control treaties. The NDPS Act carries penalties of up to 10 years for cultivation. Trafficking can draw 20 years.

Cultural and Economic Stakes

Cannabis has been used in India for thousands of years in religious ceremonies, traditional medicine, and as bhang during festivals like Holi. Reform advocates argue that prohibition has criminalized practices with deep cultural legitimacy while creating a massive illicit market.

The economic opportunity is straightforward: India's climate and agricultural expertise position it as a potential global supplier if policy shifts. Thailand legalized cannabis in 2022. Pakistan debated industrial hemp in 2020. India risks ceding regional market share.

Medical Cannabis Pressure Points

Indian states have begun carving out exceptions for medical research and industrial hemp. Uttarakhand licensed hemp cultivation in 2015. Madhya Pradesh and Uttar Pradesh followed with pilot programs. But the central government hasn't moved on broader medical access.

The regulatory patchwork creates confusion for farmers, researchers, and patients while leaving the illicit market untouched.

International Momentum

Global cannabis reform has accelerated since 2020. Germany, Thailand, and Malta legalized adult use. The UN reclassified cannabis in 2020. India participated in the UN Commission on Narcotic Drugs vote but abstained on key measures.

For full background on this story, see the CannIntel topic hub on India Cannabis Reform.

Enforcement Reality

India's NDPS enforcement is uneven. Low-level possession cases clog courts while large-scale trafficking networks operate with relative impunity. The National Crime Records Bureau reported 67,000 NDPS arrests in 2024, most for small quantities.

  • Average case pendency: 3-5 years
  • Conviction rate under NDPS: 22% (2024 data)
  • Estimated illicit market size: $4-7 billion annually

Political Obstacles

Cannabis reform faces entrenched opposition from law enforcement agencies and conservative political factions who frame legalization as a threat to public health. The Ministry of Social Justice and Empowerment has consistently opposed liberalization, citing substance abuse concerns.

No major political party has endorsed adult-use legalization. Medical cannabis proposals have stalled in parliamentary committees.

What Comes Next

The Statesman editorial adds institutional weight to a debate that's largely been confined to advocacy groups and academic circles. Whether it signals broader elite consensus remains unclear. The next legislative session begins in August 2026.

We'll be watching three indicators: state-level hemp expansion, central government statements on UN cannabis treaties, and whether opposition parties adopt reform as a campaign issue ahead of 2029 elections.

Sources

Indiacannabis reformNDPS ActStatesman editorialinternational policyAyurvedic medicine
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Laws

More from the newsroom